article thumbnail

Clinical Trial Outsourcing with Anca Copaescu

Clinical Trial Podcast

Anca and her team are helping biopharmaceutical companies plan and budget clinical trials, select and manage clinical trial suppliers, and contracts using software applications. Prior to her work at Strategikon, Anca served as the Sr.

article thumbnail

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal


Four years after being taken private, Parexel has been sold again, with Goldman Sachs’ private equity arm and EQT paying $8.5 billion to claim ownership of the contract research organisation. billion.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

CROs offer an established infrastructure to develop, initiate, execute, and progress drug discovery programs towards the clinic. Outsourcing can alleviate unnecessary backlogs and provide access to cutting-edge technologies, giving companies an edge to reach critical discovery milestones in a timely manner.

Reagent 52
article thumbnail

Modernizing Pharmacovigilance Outsourcing


Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharma companies.